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Background
Diffuse myocardial fibrosis is an important pathophysio-
logical process involved into essential hypertension
which may increase myocardium stiffness, cause ventri-
cular remodeling and increase adverse cardiovascular
risk eventually. It is strongly evident that optimal antihy-
pertensive therapy will reduce the risk induced by
hypertension, however, very few proportion of patients
with hypertension can reach the recommended target of
blood pressure (BP) control. So far little knowledge has
been illuminated for effect of blood pressure control sta-
tus on the myocardial fibrosis in hypertension. T1 map-
ping and extracellular volume (ECV) quantified by CMR
has been adopted as a good method in examination of dif-
fuse fibrosis. Besides, variation of serum fibrosis biomar-
kers may also reflect the degree of myocardial fibrosis.
Based on the above we hypothesised that there was a cor-
relation between ECV, serum fibrotic biomarkers and
long-term BP control status in patients with essential
hypertension.
Methods
T1 mapping by using modified Lock-Locker inversion
recovery(MOLLI) sequence on a 3.0 Tesla scanner was
performed on 40 hypertension patients (20 patients with
documented well BP control and 20 with uncontrolled BP)
and 20 healthy controls. Myocardial native, post T1 and
average ECV of left ventricle were measured based on pre
contrast and post contrast T1 mapping(15 minutes after
intravenous injection with gadopentetate dimeglumine
(0.15 mmol/kg). Serum PICP and ICTP level were
detected with ELISA kits.
Results
Uncontrolled hypertensive patients had a higher inter-
ventricular septum thickness(IVS) or left ventricular
mass index(LVMI) than well controlled hypertensive
patients, whereas there was no difference in left ventricu-
lar functional parameters between two groups. Hyperten-
sive patients had higher mean ECV of left ventricular
myocardium than normal controls, furthermore, mean
ECV of LV in hypertensive patients with uncontrolled BP
was higher than in patients with ECV well- controlled
(29.4 ± 3.1 vs. 27.6 ± 2.1, p = 0.01),whereas the differ-
ences of native or post-contrast T1 time of LV myocar-
dium between the two groups was not statistically
significant (p = 0.75 and 0.19, respectively) (Table 1). By
multi variants analysis, LVMI was independently corre-
lated with ECV. PICP and the ratio of PICP/ICTP
showed a trend towards higher in hypertension patients
with uncontrolled BP than well-controlled (76.6 ± 13 ug/
L vs. 66.82 ± 15.3 ug/L, p = 0.59 and 73.22 ± 13.6 vs.
66.82 ± 15.3, p = 0.96, respectively), and it was proved
that there were correlations between increased ECV and
elevated serum fibrosis biomarkers level (PICP: b = 0.37,
p = 0.02, PICP/ICTP: b = 0.30, p = 0.03) (Table 2).
Conclusions
ECV of LV myocardium was higher in hypertensive
patients which was associated with BP control status.
ECV could be associated with the LV hypertrophy in
patients with uncontrolled hypertension and could also
reflect the changes of myocardial fibrosis in hypertension.
1Sichuan Province People’s Hospital, Chengdu, China
Full list of author information is available at the end of the article
Duan et al. Journal of Cardiovascular Magnetic
Resonance 2016, 18(Suppl 1):P125
http://www.jcmr-online.com/content/18/S1/P125
© 2016 Duan et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Authors’ details
1Sichuan Province People’s Hospital, Chengdu, China. 2Cardiology
Department, Sichuan University West China Hospital, Chengdu, China. 3MR
Collaborations NE Asia, Siemens Healthcare, Beijing, China.
Published: 27 January 2016
doi:10.1186/1532-429X-18-S1-P125
Cite this article as: Duan et al.: Extracellular volume(ECV) quantified by
T1 mapping could reflect effect of long term blood pressure control
status in patients with essential hypertension. Journal of Cardiovascular
Magnetic Resonance 2016 18(Suppl 1):P125.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Table 1 Cardiac Magnetic Resonance Imaging data.
Well-controlled BP(n = 20) Uncontrolled BP (n = 20) Control (n = 20) P value
LVEDV, ml 112.7 ± 23.8 121.6 ± 19.7 109.3 ± 17.8 >0.05
LVESV, ml 40.7 ± 9.2 46.3 ± 1.4 39.8 ± 1.0 >0.05
LVEDVI, ml/BSA 67.5 ± 11.9 68.1 ± 12.1 68.3 ± 10.7 >0.05
LVESVI, ml/BSA 24.5 ± 4.9 25.6 ± 7.9 25.6 ± 6.4 >0.05
LVM, g 75.8 ± 15.6* 82.1 ± 17.4* 63.8 ± 12.8 <0.05
LVMI, g/BSA 45.4 ± 8.2 46.0 ± 9.6 41.8 ± 9.5 >0.05
IVS, mm 8.7 ± 1.0* 9.9 ± 2.7**# 7.4 ± 1.2 <0.001
LVEF, % 63.5 ± 5.7 61.6 ± 6.7 63.1 ± 7.1 >0.05
SV, ml 71.8 ± 18.3 74.4 ± 12.5 68.1 ± 13.1 >0.05
Native myocardium T1 time, msec 1257 ± 61 1271 ± 58 1233 ± 66 >0.05
Post-contrast T1 time, msec 461 ± 43 443 ± 47 474 ± 44 >0.05
ECV, % 27.6 ± 2.1* 29.4 ± 3.1**# 26.1 ± 1.6 <0.001
Values are mean ± SD
LVEDV = left ventricular end-diastolic volume; LVESV = left ventricular end-systolic volume; BSA = body surface area; LVEDVI = left ventricular end-diastolic
volume index; LVESVI = left ventricular end-systolic volume index; LVM=left ventricular mass; LVMI=left ventricular mass index; IVS= interventricular septum; LVEF
= left ventricular ejection fraction; SV= stroke volume; ECV = extracellular volume fraction;
* p <0.05 vs.control, ** p <0.001 vs.control, # p <0.05 vs. Well-controlled BP group (LSD post-hoc tests for differences)
Table 2 Relationship of serum fibrosis biomarkers with demographic T1 mapping data
PICP ICTP PICP/ICTP
r P value b P value r P value r P value b P value
Age, yrs 0.20 0.11 0.14 0.26 0.10 0.44
BMI, kg/m2 0.01 0.94 0.14 0.29 0.23 0.07
SBP, mmHg 0.15 0.25 0.18 0.16 0.25* 0.04 -0.19 0.32
DBP, mmHg 0.28* 0.03 0.11 0.46 0.17 0.18 0.27* 0.03 0.36 0.06
LVEF, % 0.20 0.12 0.16 0.23 -0.16 0.20
LV mass, g 0.18 0.15 0.28* 0.03 -0.07 0.68
IVS, mm 0.27* 0.03 -0.05 0.78 0.04 0.80 0.24 0.06
Native T1 time, msec 0.16 0.21 0.01 0.92 0.16 0.20
Post-contrast T1 time, msec 0.05 0.67 -0.08 0.53 0.10 0.42
ECV, % 0.4* 0.01 0.37* 0.02 0.07 0.60 0.37* 0.003 0.30* 0.03
Values are mean ± SD.
PICP: carboxy-terminal propeptide of procollagen type I; ICTP: carboxy-terminal telopeptide of collagen type I; BMI = body mass index; SBP = systolic blood
pressure, DBP = diastolic blood pressure; LVEF = left ventricular ejection fraction; IVS = interventricular septum; ECV = extracellular volume fraction.
* p <0.05.
Duan et al. Journal of Cardiovascular Magnetic
Resonance 2016, 18(Suppl 1):P125
http://www.jcmr-online.com/content/18/S1/P125
Page 2 of 2
